3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Breast Neoplasms
2
Radiation Injuries
1
Peripheral Nervous System Diseases
1
Multiple Myeloma
1
Gangliosidosis, GM1
1
Gangliosidoses
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Brain Neoplasms
1
Interventions
Radiotherapy
29
Cisplatin
12
Amifostine
11
Radiotherapy, Intensity-Modulated
7
Paclitaxel
7
Carboplatin
7
Etoposide
5
Radiosurgery
4
Donepezil
4
Brachytherapy
4
Bevacizumab
4
sargramostim
3
Surgical Procedures, Operative
3
Mental Status and Dementia Tests
3
Filgrastim
3
Diet Therapy
3
Blood Specimen Collection
3
Radiation Dose Hypofractionation
2
Radiation
2
Proton Therapy
2
Magnetic Resonance Spectroscopy
2
Low-Level Light Therapy
2
Lithium
2
Hyperbaric Oxygenation
2
Heavy Ion Radiotherapy
2
Fluorouracil
2
Fibroblast Growth Factor 7
2
Dexamethasone
2
Chemotherapy, Adjuvant
2
Androgen Antagonists
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Radiation Injuries
×
G(M1) Ganglioside
×
Clear all
NCT04395339
2024-08-01
GLORY
Sun Yat-sen University
Phase 3
Terminated
51 enrolled